首页> 外国专利> Routing gpc3 to administer drugs to a patient who responds to the Drug Therapy to gpc3 routing

Routing gpc3 to administer drugs to a patient who responds to the Drug Therapy to gpc3 routing

机译:将gpc3路由到对gpc3路由对药物疗法有反应的患者用药

摘要

Method for determining the effectiveness of Drug Therapy to gpc3 Routing in a Cancer Patient before the start of the Drug Therapy for a patient to gpc3 routing or to determine the continuation of Drug Therapy to gpc3 Pair routing A patient,That includes the monitoring of concentration of Free gpc3 isolated in a Biological sample from the patient before the start of therapy with drugs to gpc3 Routing and / or in the patient treated with Drug Therapy to gpc3 routing, where the concentration of gpc3 Free is a Predetermined value,Determines the effectiveness of Drug Therapy or routing is determined to gpc3 continued Therapy with drugs to gpc3 routing.This application also describes a routing to gpc3 drug or preparation to be administered to a patient for whom it has determined the effectiveness of Drug Therapy or routing has been determined to gpc3 continued Therapy with drugs To gpc3 routing.
机译:在开始对gpc3路线进行药物治疗之前确定癌症患者中对gpc3路线进行药物治疗的有效性的方法或确定对gpc3路线进行药物治疗的持续性的方法对患者,包括监测药物的浓度在开始用gpc3途径进行药物治疗之前从患者的生物学样品中分离出的游离gpc3和/或在用药物疗法治疗过的gpc3途径进行治疗的患者中,其中gpc3 Free的浓度为预定值,确定了确定对gpc3的药物治疗或途径是继续进行药物对gpc3途径的治疗。本申请还描述了对gpc3药物或要对已确定药物治疗有效的患者进行给药的制剂或对gpc3的途径继续用药物疗法至gpc3路由。

著录项

  • 公开/公告号AR094269A1

    专利类型

  • 公开/公告日2015-07-22

    原文格式PDF

  • 申请/专利权人 CHUGAI SEIYAKU KABUSHIKI KAISHA;

    申请/专利号AR2013P105015

  • 发明设计人

    申请日2013-12-20

  • 分类号G01N33/48;A61K39/395;A61K45;A61P1/16;A61P35;G01N33/53;G01N33/574;

  • 国家 AR

  • 入库时间 2022-08-21 15:16:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号